Medpace Holdings, Inc. (MEDP) Financials

MEDP Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 2.1 billion 1.6 billion
March 31, 2026 2.1 billion 1.5 billion
Dec. 31, 2025 2.0 billion 1.5 billion
Sept. 30, 2025 1.8 billion 1.5 billion

MEDP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 138.1 million 4.3 million
March 31, 2026 145.0 million 4.9 million
Dec. 31, 2025 188.1 million 5.6 million
Sept. 30, 2025 262.3 million 6.3 million

MEDP Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 121.4 million
March 31, 2026 123.9 million
Dec. 31, 2025 135.1 million
Sept. 30, 2025 111.1 million

MEDP Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 502.7 million - 120.1 million
March 31, 2026 652.7 million - 122.3 million
Dec. 31, 2025 497.0 million 113.6 million 113.6 million
Sept. 30, 2025 285.4 million - 119.1 million

MEDP Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 28.8 million
March 31, 2026 29.0 million
Dec. 31, 2025 29.0 million
Sept. 30, 2025 29.7 million

MEDP Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 23.9 million - 48.1 million -
March 31, 2026 6.8 million - 47.9 million -
Dec. 31, 2025 4.5 million - 44.9 million -
Sept. 30, 2025 16.1 million - 48.1 million -

MEDP Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 707.3 million 505.7 million
March 31, 2026 706.6 million 510.3 million
Dec. 31, 2025 708.5 million 503.1 million
Sept. 30, 2025 659.9 million 463.0 million

MEDP Revenue by Segment
Graph available only for paid members. Upgrade to see it.

MEDP

Price: $591.29

52 week price:
373.00
677.90

Earnings Per Share: 16.68 USD

P/E Ratio: 35.33

Exchange: NMS

Sector: Healthcare

Industry: Diagnostics & Research

Country: United States

Volume: 218368

Ebitda: 28.9 million

Market Capitalization: 16.5 billion

Links: